Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy
- PMID: 38001645
- PMCID: PMC10670143
- DOI: 10.3390/cancers15225385
Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy
Abstract
A simple way to understand the immune system is to separate the self from non-self. If it is self, the immune system tolerates and spares. If it is non-self, the immune system attacks and destroys. Consequently, if cancer has a stem cell origin and is a stem cell disease, we have a serious problem and a major dilemma with immunotherapy. Because many refractory cancers are more self than non-self, immunotherapy may become an uphill battle and pyrrhic victory in cancer care. In this article, we elucidate cancer immunity. We demonstrate for whom, with what, as well as when and how to apply immunotherapy in cancer care. We illustrate that a stem cell theory of cancer affects our perspectives and narratives of cancer. Without a pertinent theory about cancer's origin and nature, we may unwittingly perform misdirected cancer research and prescribe misguided cancer treatments. In the ongoing saga of immunotherapy, we are at a critical juncture. Because of the allure and promises of immunotherapy, we will be treating more patients not immediately threatened by their cancer. They may have more to lose than to gain, if we have a misconception and if we are on a wrong mission with immunotherapy. According to the stem cell theory of cancer, we should be careful with immunotherapy. When we do not know or realize that cancer originates from a stem cell and has stem-ness capabilities, we may cause more harm than good in some patients and fail to separate the truth from the myth about immunotherapy in cancer care.
Keywords: autoimmunity; cancer stem cell; cancer vaccine; heterogeneity; hyper-progression; immunotherapy; microbiome; microenvironment.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care.Cancers (Basel). 2024 Mar 14;16(6):1151. doi: 10.3390/cancers16061151. Cancers (Basel). 2024. PMID: 38539487 Free PMC article.
-
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.Prog Mol Biol Transl Sci. 2019;164:119-188. doi: 10.1016/bs.pmbts.2019.03.008. Epub 2019 Apr 11. Prog Mol Biol Transl Sci. 2019. PMID: 31383404 Review.
-
Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity.Cancers (Basel). 2021 Aug 9;13(16):4006. doi: 10.3390/cancers13164006. Cancers (Basel). 2021. PMID: 34439162 Free PMC article.
-
Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells.Acta Biomater. 2023 Apr 15;161:1-36. doi: 10.1016/j.actbio.2023.03.004. Epub 2023 Mar 10. Acta Biomater. 2023. PMID: 36907233 Review.
-
Stem Cell Theory of Cancer: Origin of Metastasis and Sub-clonality.Semin Diagn Pathol. 2023 Jan;40(1):63-68. doi: 10.1053/j.semdp.2022.06.012. Epub 2022 Jun 15. Semin Diagn Pathol. 2023. PMID: 35729019 Review.
Cited by
-
CYP26A1 Links WNT and Retinoic Acid Signaling: A Target to Differentiate ALDH+ Stem Cells in APC-Mutant CRC.Cancers (Basel). 2024 Jan 7;16(2):264. doi: 10.3390/cancers16020264. Cancers (Basel). 2024. PMID: 38254755 Free PMC article.
-
Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care.Cancers (Basel). 2024 Mar 14;16(6):1151. doi: 10.3390/cancers16061151. Cancers (Basel). 2024. PMID: 38539487 Free PMC article.
References
-
- Tu S.M. In: Origin of Cancers. Clinical Perspectives and Implications of a Stem-Cell Theory of Cancer. Rosen S.T., editor. Volume 154 Springer; New York, NY, USA: 2010. Cancer Treatment and Research. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources